Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Body Focused Repetitive Behaviors
NCT05545891Phase 2Not yet recruiting
- Sponsor
- University of Chicago
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aripiprazole in trichotillomania (TTM), Excoriation Disorder, sponsored by University of Chicago. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
aripiprazole
03
Conditions
trichotillomania (TTM)Excoriation Disorder
Beyond the preview
Go deeper on NCT05545891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05545891.